Epicutaneous Immunotherapy in Peanut Allergy in Children

NCT01197053 ↗

Phase 2 Completed 60 enrolled Assistance Publique - Hôpitaux de Paris DBV Technologies · collab

RandomizedCrossoverDouble-blindTreatment

Summary

This study aims at showing that Epicutaneous Immunotherapy with peanut proteins is safe and efficacious for desensitizing children with peanut allergy.

Timeline

Start: 2010-08
Primary completion: 2015-02
Completion: 2015-04

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	DEFATTED POWDER OF ARACHIS HYPOGAEA L., SEMEN (PEANUTS)	Protein / enzyme biologic	100 ug	Other

Epicutaneous Immunotherapy in Peanut Allergy in Children

Summary

Timeline

Drugs

Indications